The Conundrum of Anticoagulation and Antiplatelet Therapy in Spontaneous Coronary Artery Dissection

Area of Science:

• Cardiology
• Vascular Medicine
• Medical Research

Background:

• Spontaneous coronary artery dissection (SCAD) is an uncommon yet significant cause of myocardial infarction, particularly in younger women.
• Existing knowledge regarding SCAD pathophysiology and optimal management strategies remains limited, often relying on anecdotal evidence and hypotheses.
• Current treatment guidelines for SCAD are not well-established, leading to diagnostic and therapeutic challenges.

Observation:

• A patient with a history of recurrent SCAD experienced clinical deterioration following the cessation of anticoagulant therapy.
• This adverse event prompted a re-evaluation of the patient's treatment regimen and a review of existing literature.
• The patient's worsening condition underscored the potential role of anticoagulation in preventing SCAD recurrence.

Findings:

• The case highlights a potential link between anticoagulation status and SCAD recurrence, challenging the hypothesis that anticoagulation is not indicated in SCAD.
• A review of current evidence suggests a complex interplay between SCAD pathophysiology, anticoagulation, and antiplatelet therapy.
• The findings indicate a need for further investigation into the efficacy and safety of anticoagulation in specific SCAD patient populations.

Implications:

• This case report necessitates a critical re-examination of current SCAD management protocols, particularly concerning anticoagulation therapy.
• Further research is warranted to elucidate the precise role of anticoagulation and antiplatelet agents in the long-term management of SCAD.
• Clinicians should consider individual patient factors and evolving evidence when making treatment decisions for recurrent SCAD.